Neuropathological criteria for the diagnosis of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Neurobiology of Aging

• Publication date

  1997-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0197-4580(97)00064-XPMID 9330980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Senile plaques do not progressively accumulate with normal aging

  2004cited by this paper
• Quantitative immunohistochemical analysis of the distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of nonagenarians and centenarians

  2004cited by this paper
• Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects

  2004cited by this paper
• Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.

  1997cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.

  1996cited by this paper
• BRAAK STAGES III-IV OF ALZHEIMER-RELATED NEUROPATHOLOGY ARE ASSOCIATED WITH MILD MEMORY LOSS, STAGES V-VI ARE ASSOCIATED WITH DEMENTIA: FINDINGS FROM THE NUN STUDY

  1996cited by this paper
• Neocortical Lewy Body Counts Correlate with Dementia in the Lewy Body Variant of Alzheimer's Disease

  1996cited by this paper
• Cerebral amyloid deposition and diffuse plaques in ``normal'' aging

  1996cited by this paper
• β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease

  1996cited by this paper
• Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.

  1995cited by this paper
• Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity

  1995cited by this paper
• Absence of Abnormal Hyperphosphorylation of Tau in Intracellular Tangles in Alzheimer's Disease

  1995cited by this paper
• Color image analysis in neuroanatomical research: application to senile plaque subtype quantification in Alzheimer's disease.

  1995cited by this paper
• Decreased Activity of Hippocampal Neurons in Alzheimer's Disease Is Not Related to the Presence of Neurofibrillary Tangles

  1995cited by this paper
• The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype.

  1995cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease

  1995cited by this paper
• Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.

  1995cited by this paper
• Single section and disector counts in evaluating neuronal loss from the substantia nigra in patients with Parkinson's disease

  1995cited by this paper
• Dystrophic neurites define diffuse as well as core-containing senile plaques in Alzheimer's disease.

  1995cited by this paper
• Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits

  1995cited by this paper
• Correlations of synaptic and pathological markers with cognition of the elderly.

  1995cited by this paper
• Cortical Lewy bodies in Alzheimer's disease.

  1995cited by this paper
• Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans.

  1994cited by this paper
• No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type.

  1994cited by this paper
• Interlaboratory Comparison of Neuropathology Assessments in Alzheimer's Disease: A Study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1994cited by this paper
• An extensive network of PHFτ‐rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease

  1994cited by this paper
• Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population

  1994cited by this paper
• A modified NOR–silver impregnation technique for amyloid plaques and neurofibrillary tangles: comparative assessment

  1994cited by this paper
• Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital.

  1994cited by this paper
• Alzheimer's disease and Lewy body disease: A comparative clinicopathological study

  1994cited by this paper
• Immunohistochemical Staging of Neurofibrillary Degeneration in Alzheimer's Disease

  1994cited by this paper
• Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease.

  1994cited by this paper
• Pathological markers associated with normal aging and dementia in the elderly

  1993cited by this paper
• An unbiased correction factor for cell counts in histological sections.

  1993cited by this paper
• Alzheimer plaque density and duration of dementia.

  1993cited by this paper
• The Clinical Dementia Rating (CDR)

  1993cited by this paper
• Temporal Sequence of Plaque Formation in the Cerebral Cortex of Non-Demented Individuals

  1993cited by this paper
• Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes.

  1993cited by this paper
• Plaque‐Only Alzheimer Disease is Usually the Lewy Body Variant, and Vice Versa

  1993cited by this paper
• Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar?

  1993cited by this paper
• Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older.

  1993cited by this paper
• Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists.

  1993cited by this paper
• Clinicopathologic Correlates in Alzheimer Disease: Assessment of Clinical and Pathologic Diagnostic Criteria

  1993influential reference
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Lewy body dementia.

  1992cited by this paper
• Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia

  1992cited by this paper
• Quantification of plaque types in sulci and gyri of the medial frontal lobe in patients with Alzheimer's disease.

  1992cited by this paper
• Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease

  1992cited by this paper
• Some Immunohistochemical Features of Argyrophilic Grain Dementia With Normal Cortical Choline Acetyltransferase Levels but Extensive Subcortical Pathology and Markedly Reduced Dopamine

  1992cited by this paper
• A topographical pathway by which histopathological lesions disseminate through the brain of patients with Alzheimer's disease

  1991cited by this paper
• Alz‐50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease

  1991cited by this paper
• Pathology of Alzheimer's disease.

  1991influential reference
• Very mild Alzheimer's disease

  1991cited by this paper
• The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.

  1991cited by this paper
• Neuritic pathology and dementia in alzheimer's disease

  1991cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991influential reference
• Clinical diagnosis of Alzheimer's disease

  1991cited by this paper
• Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy?

  1991cited by this paper
• The Lewy body variant of Alzheimer's disease

  1990cited by this paper
• 3. Recent progress in the characterization of the pathological hallmarks for Alzheimer's disease

  1990cited by this paper
• Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.

  1989cited by this paper
• COMPARISON OF SEVEN STAINING METHODS FOR SENILE PLAQUES AND NEUROFIBRILLARY TANGLES IN A PROSPECTIVE SERIES OF 15 ELDERLY PATIENTS

  1989cited by this paper
• Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.

  1989cited by this paper
• CORTICAL AND SUBCORTICAL ARGYROPHILIC GRAINS CHARACTERIZE A DISEASE ASSOCIATED WITH ADULT ONSET DEMENTIA

  1989influential reference
• A case of adult‐onset dementia with argyrophilic grains

  1989cited by this paper
• Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

  1988cited by this paper
• Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases

  1988influential reference
• Diagnosis of Alzheimer's disease.

  1988influential reference
• The NINCDS‐ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease

  1988cited by this paper
• Neuron numbers and dendritic extent in normal aging and Alzheimer's disease.

  1987cited by this paper
• Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes.

  1987influential reference
• Senile Dementia of the Alzheimer Type Without Neocortical Neurofibrillary Tangles

  1987cited by this paper
• A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.

  1987cited by this paper
• Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients

  1987cited by this paper
• Parkinson's disease in patients with Alzheimer's disease.

  1986cited by this paper
• [Neuropathological study of 12 centenarians: the incidence of Alzheimer type senile dementia is not particularly increased in this group of very old patients].

  1986cited by this paper
• Head injury as a risk factor for Alzheimer's disease

  1985cited by this paper
• DEMENTIA: A CLINICAL APPROACH

  1985cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper
• The unbiased estimation of number and sizes of arbitrary particles using the disector

  1984cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• The Morphological Basis of Dementia in Parkinson’s Disease

  1984cited by this paper
• Alzheimer's disease: A study of epidemiological aspects

  1984cited by this paper
• A Guide to Practical Stereology

  1983cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper
• A quantitative study of cerebral atrophy in old age and senile dementia.

  1981cited by this paper
• Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

  1978cited by this paper
• Histometric observations on the metabolism of tangle-bearing neurons.

  1973cited by this paper
• The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

  1968cited by this paper
• Hierarchical Grouping to Optimize an Objective Function

  1963cited by this paper
• Estimation of nuclear population from microtome sections

  1946cited by this paper

• Classification of Alzheimer’s disease in a mixed clinical cohort using biofluid Raman spectroscopy

  2025cites this paper
• Physiopathological mechanisms underlying Alzheimer’s disease: a narrative review

  2024cites this paper
• Label-free autofluorescence and hyperspectral imaging of cerebral amyloid-β lesions in aged squirrel monkeys

  2023cites this paper
• Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer’s disease

  2023cites this paper
• Amyloid‐β PET in Alzheimer's disease: A systematic review and Bayesian meta‐analysis

  2022influential citation
• Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study

  2021cites this paper
• Ubiquitin carboxyl-terminal hydrolase L-1 in brain: Focus on its oxidative/nitrosative modification and role in brains of subjects with Alzheimer disease and mild cognitive impairment.

  2021cites this paper
• Pursuit of precision medicine: Systems biology approaches in Alzheimer’s disease mouse models

  2021cites this paper
• BRAIN LIPID PEROXIDATION AND ALZHEIMER DISEASE: SYNERGY BETWEEN THE BUTTERFIELD AND MATTSON LABORATORIES.

  2020cites this paper
• Tau and Amyloid-β Pathology in Japanese Forensic Autopsy Series Under 40 Years of Age: Prevalence and Association with APOE Genotype and Suicide Risk

  2019cites this paper
• The influence of life course vascular risk on brain pathologies and cognition in later life - a neuroimaging study of the British 1946 birth cohort

  2019cites this paper
• Retraction Retracted : Decursin Isolated from Angelica gigas Nakai Rescues PC 12 Cells from Amyloid β-Protein-Induced Neurotoxicity through Nrf 2-Mediated Upregulation of Heme Oxygenase-1 : Potential Roles of MAPK Evidence-Based Complementary and Alternative Medicine

  2019cites this paper
• Comparison of Amyloid β and Tau Spread Models in Alzheimer's Disease.

  2018cites this paper
• Higher levels of thyroxine may predict a favorable response to donepezil treatment in patients with Alzheimer disease: a prospective, case–control study

  2018cites this paper
• Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease

  2018cites this paper
• mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease‐like dementia

  2018cites this paper
• Possible Role of Common Spices as a Preventive and Therapeutic Agent for Alzheimer's Disease

  2017cites this paper
• Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid

  2017cites this paper
• Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.

  2017cites this paper
• Association between tau deposition and antecedent amyloid-&bgr; accumulation rates in normal and early symptomatic individuals

  2017cites this paper
• Neuronal tetraploidization in the cerebral cortex correlates with reduced cognition in mice and precedes and recapitulates Alzheimer's-associated neuropathology.

  2017cites this paper
• Demencia: estados preclínicos y mortalidad en cohortes suecas

  2016cites this paper
• Estrogen receptor-α is localized to neurofibrillary tangles in Alzheimer’s disease

  2016cites this paper
• Precortical Phase of Alzheimer's Disease (AD)‐Related Tau Cytoskeletal Pathology

  2016cites this paper
• Structural imaging of hippocampal subfields in healthy aging and Alzheimer's disease.

  2015cites this paper
• Integrated Whole Transcriptome and DNA Methylation Analysis Identifies Gene Networks Specific to Late-Onset Alzheimer's Disease

  2015cites this paper
• Inhibition of PMCA activity by tau as a function of aging and Alzheimer's neuropathology.

  2015cites this paper
• Lifestyle-related Risk Factors Associated with Alzheimer's Disease: A Systematic Review of the Literature

  2015cites this paper
• Deciphering Transcription and Methylation Specific to Late-Onset Alzheimer's Disease

  2014influential citation
• Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?

  2014cites this paper
• Alzheimer ’ s Disease Clinical characteristics of late-onset Alzheimer ’ s disease ( LOAD ) Dr

  2013cites this paper
• Neuropathological diagnosis of alzheimer ' s disease : the relationship between postmortem assessment , cognitive function and functional status in

  2013cites this paper
• Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid β-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPK

  2013cites this paper
• Neuroprotective Effects of a Variety of Pomegranate Juice Extracts against MPTP-Induced Cytotoxicity and Oxidative Stress in Human Primary Neurons

  2013cites this paper
• OXIDATIVE DAMAGE TO DNA IN ALZHEIMER'S DISEASE

  2013influential citation
• Alzheimer's Disease Clinical Characteristics of Late-onset Alzheimer's Disease (load) Diagnostic and Statistical Manual of Mental Disorders -fourth Edition -text Revised (dsm-iv-tr), and the World Health Organisation in the International

  2013cites this paper
• Ablation of inducible nitric oxide synthase does not alter Alzheimer's like pathology in transgenic mice

  2012cites this paper
• Oxidative lipid modification of nicastrin enhances amyloidogenic γ‐secretase activity in Alzheimer’s disease

  2012cites this paper
• University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.

  2012cites this paper
• Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer disease subjects

  2011cites this paper
• Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.

  2011cites this paper
• Nutritional approaches to modulate oxidative stress in Alzheimer's disease.

  2011cites this paper
• Neuropathological diagnosis of Alzheimer's Disease: The relationship between postmortem assessment, cognitive function and functional status in centenarians

  2011cites this paper
• The wheat germ agglutinin‐fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression

  2010cites this paper
• Insulin-Resistant Brain State after Intracerebroventricular Streptozotocin Injection Exacerbates Alzheimer-like Changes in Tg2576 AβPP-Overexpressing Mice

  2010cites this paper
• Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer

  2010cites this paper
• Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.

  2010cites this paper
• Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” A national registry on aging

  2009cites this paper
• Statistical and Data Mining Methodologies for Behavioral Analysis in Transgenic Mouse Models of Alzheimer's Disease: Parallels with Human AD Evaluation

  2009cites this paper
• Small heat shock proteins Hsp27 or αB‐crystallin and the protein components of neurofibrillary tangles: Tau and neurofilaments

  2008cites this paper
• Tau and neurofilament proteins in Alzheimer's disease and related cell models

  2007cites this paper
• A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.

  2007cites this paper
• Recent advances in the development of amyloid imaging agents.

  2007cites this paper
• Primary Prevention and Delay of Onset of AD/Dementia

  2007cites this paper
• Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesterase.

  2007cites this paper
• Autoantibodies to amyloid β-peptide (Aβ) are increased in Alzheimer’s disease patients and Aβ antibodies can enhance Aβ neurotoxicity

  2007cites this paper
• Neuroprotective effect by Dammishimgyu-herbal acupuncture against H2O2-induced apoptosis in human neuroblastoma, SH-SY5Y cells

  2007cites this paper
• Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease.

  2007cites this paper
• Apoptotic cell death in neural stem cells exposed to toxic stimuli

  2007cites this paper
• Neural substrates of cognitive and behavioral deficits in atypical Alzheimer's disease.

  2006cites this paper
• Age-related neuropathology, cognitive decline, and Alzheimer's disease.

  2006cites this paper
• Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.

  2006cites this paper
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

  2006cites this paper
• Biophysical and biochemical characterization of the intrinsic fluorescence from neurofibrillary tangles.

  2006cites this paper
• Interplay Between Oxidative Damage, Protein Synthesis, and Protein Degradation in Alzheimer's Disease

  2006cites this paper
• Cholesterol-Depleting Statin Drugs Protect Postmitotically Differentiated Human Neurons against Ethanol- and Human Immunodeficiency Virus Type 1-Induced Oxidative Stress In Vitro

  2006cites this paper
• Statin use and the risk of Alzheimer's disease: The MIRAGE Study

  2006cites this paper
• Tau protein aggregation in the frontal and entorhinal cortices as a function of aging.

  2005cites this paper
• The Cyclopentenone (A2/J2) Isoprostanes—Unique, Highly Reactive Products of Arachidonate Peroxidation

  2005cites this paper
• Multiplex method for measuring biomarkers of Alzheimer disease in cerebrospinal fluid.

  2005cites this paper
• Development of an optical approach for noninvasive imaging of Alzheimer's disease pathology.

  2005cites this paper
• Long-term potentiation and memory.

  2004cites this paper
• Profiling proteins related to amyloid deposited brain of Tg2576 mice

  2004cites this paper
• Fluorescence resonance energy transfer determinations using multiphoton fluorescence lifetime imaging microscopy to characterize amyloid-beta plaques.

  2003cites this paper
• Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development.

  2003cites this paper
• C-Terminal Fragments of Amyloid-β Peptide Cause Cholinergic Axonal Degeneration by a Toxic Effect Rather Than by Physical Injury in the Nondemented Human Brain

  2003cites this paper
• Expression and Distribution of Carboxypeptidase B in the Hippocampal Subregions of Normal and Alzheimer’s Disease Brain

  2003influential citation
• Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic mice

  2003cites this paper
• Alzheimer’s Disease: What Multiphoton Microscopy Teaches Us

  2002cites this paper
• Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria

  2002cites this paper
• Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-β In Vivo by Immunotherapy

  2002cites this paper
• Types of Age-Related Brain Lesions and Relationship to Neuropathologic Diagnostic Systems of Alzheimer's Disease

  2001cites this paper
• Serum p97 levels as an aid to identifying Alzheimer's disease

  2001cites this paper
• A novel fluorescent method for direct visualization of neurofibrillary pathology in Alzheimer's disease.

  2001cites this paper
• Practical measures to simplify the Braak tangle staging method for routine pathological screening

  2000cites this paper
• Density profiles of Alzheimer disease regional brain pathology for the huddinge brain bank: pattern recognition emulates and expands upon Braak staging.

  2000cites this paper
• Peripheral Markers of Alzheimer’s

  2000cites this paper
• Early Diagnosis of Alzheimer’s Disease

  2000cites this paper
• Plasma cortisol levels in elderly female subjects with Alzheimer's disease: a cross-sectional and longitudinal study.

  2000cites this paper
• Alzheimer's disease: a neuropathologic perspective

  1998cites this paper